daunorubicin has been researched along with Hematologic Diseases in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (52.17) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Z; Ding, B; Li, Y; Shi, Y; Zho, J | 1 |
| Baer, M; Becknell, B; Bloomfield, CD; Caligiuri, MA; Crawford, J; Dodge, RK; Farag, SS; Fehniger, TA; George, SL; Larson, RA; Lee, EJ; Schiffer, CA; Silverman, LR | 1 |
| Bosch, SV; de Jonge, MJ; Fiorentini, F; Hess, D; Lechuga, MJ; Mantel, MA; Mora, O; Planting, AS; Sessa, C; Valota, O; van der Gaast, A; Verweij, J | 1 |
| Brandwein, J; Chun, K; Gupta, V; Minden, M; Schuh, A; Wells, R; Yi, QL | 1 |
| Aung, L; Kirk, RC; Liang, S; Quah, TC; Tan, RM; Yeoh, AE | 1 |
| Abella, E; Bastida, P; Bethencourt, C; Bueno, J; del Potro, E; Feliu, E; Fernández-Abellán, P; Grande, C; Heras, I; Oriol, A; Ortega, JJ; Parody, R; Ribera, JM; Sanz, MA; Tormo, M | 1 |
| Athens, JW; Baker, LH; Foulkes, M; Gad-el-Mawla, N; Panettiere, FJ; Smith, FE; Tranum, B | 1 |
| Benjamin, RS; Bodey, GP; Freireich, EJ; Keating, MJ; McCredie, KB; Smith, TL; Zander, A | 1 |
| Chan, K; DelaFlor-Weiss, E; Guaglianone, P; Hanisch, R; Jeffers, S; Muggia, F; Sharma, D | 1 |
| Mempel, K; Pfetsch, M; Reiter, A; Riehm, H; Schrappe, M; Schwab, G; Welte, K | 1 |
| Horikawa, K; Okada, Y; Sano, M | 1 |
| Aass, N; Fosså, SD; Parö, G | 1 |
| Earhart, RH; Maroun, JA; Robillard, L; Stewart, DJ; Verma, S | 1 |
| Aisner, J; Egorin, MJ; Sigman, LM; Van Echo, DA; Whitacre, MY | 1 |
| Brown, TD; Donehower, RC; Ettinger, DS; Grochow, LB; Rice, AP | 1 |
| Simonson, GM | 1 |
| Di Lauro, L; Di Pietro, N; Ganzina, F; Lazzaro, B; Lopez, M; Papaldo, P | 1 |
| Amoroso, D; Conte, PF; Lionetto, R; Pronzato, P; Rosso, R; Sertoli, MR | 1 |
| Höcker, P | 1 |
| Miyazaki, S; Nagayama, T; Take, H | 1 |
| Meister, H; Trux, F | 1 |
| Bianco, G; Bravi, A; Di Paolo, N; Marcolongo, R | 1 |
7 trial(s) available for daunorubicin and Hematologic Diseases
| Article | Year |
|---|---|
Homoharringtonine combined with cytarabine to treat chronic myelogenous leukemia in myeloid blast crisis and its impact on bone marrow CD34+CD7+ cells.
Topics: Adolescent; Adult; Antigens, CD34; Antigens, CD7; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow; Cell Count; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Harringtonines; Hematologic Diseases; Homoharringtonine; Humans; Immunophenotyping; Leukemia, Myeloid, Accelerated Phase; Male; Middle Aged; Mitoxantrone; Myeloid Cells; Neoplastic Stem Cells; Remission Induction; Young Adult | 2014 |
Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.
Topics: Acute Disease; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclosporins; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Fatigue; Gene Expression Regulation, Neoplastic; Hematologic Diseases; Humans; Immunologic Factors; Interleukin-2; Killer Cells, Natural; Leukemia, Myeloid; Life Tables; Middle Aged; Nausea; Neoplasm Proteins; NK Cell Lectin-Like Receptor Subfamily K; Receptors, Immunologic; Receptors, Natural Killer Cell; Recombinant Fusion Proteins; Remission Induction; Survival Analysis; Treatment Outcome | 2002 |
Phase I and pharmacokinetic studies of PNU-159548, a novel alkycycline, administered intravenously to patients with advanced solid tumours.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Daunorubicin; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Vomiting | 2002 |
Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Hematologic Diseases; Humans; Hydrocortisone; Infant; Infections; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Treatment Outcome; Vincristine | 2008 |
Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome).
Topics: Adult; Aged; Daunorubicin; Drug Carriers; Female; Hematologic Diseases; Humans; Liposomes; Male; Middle Aged | 1994 |
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fever; Filgrastim; Gastrointestinal Diseases; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Infant; Infection Control; Life Tables; Male; Mercaptopurine; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Recombinant Proteins; Risk; Survival Analysis; Thioguanine; Vincristine; Vindesine | 1996 |
A phase II study of DaunoXome in advanced urothelial transitional cell carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Chest Pain; Daunorubicin; Female; Hematologic Diseases; Humans; Liposomes; Male; Treatment Failure; Urologic Neoplasms | 1998 |
16 other study(ies) available for daunorubicin and Hematologic Diseases
| Article | Year |
|---|---|
Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy.
Topics: Acute Disease; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Hematologic Diseases; Humans; Karyotyping; L-Lactate Dehydrogenase; Leukemia, Myeloid; Leukocyte Count; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome | 2005 |
Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol.
Topics: Acute Disease; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cytarabine; Daunorubicin; Developing Countries; Disease-Free Survival; Drug Evaluation; Etoposide; Female; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Humans; Infant; Infections; Kaplan-Meier Estimate; Leukemia, Myeloid; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Prednisone; Remission Induction; Retrospective Studies; Singapore; Survival Analysis; Thioguanine; Treatment Outcome; Vincristine | 2007 |
Phase II evaluation of rubidazone (NSC-164011) in advanced carcinoma of the breast. A Southwest Oncology Group study.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Daunorubicin; Drug Evaluation; Female; Hematologic Diseases; Humans; Middle Aged; Risk; Time Factors | 1983 |
Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP).
Topics: Aged; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Pneumonia; Prednisone; Sepsis; Time Factors; Vincristine | 1981 |
[Echocardiographic evaluation of cardiotoxicity induced by anthracycline therapy].
Topics: Aclarubicin; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Doxorubicin; Echocardiography; Epirubicin; Female; Heart; Hematologic Diseases; Humans; Male; Middle Aged; Mitoxantrone; Radionuclide Imaging; Stroke Volume | 1997 |
Phase I study of oral menogaril administered on a once weekly schedule.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Menogaril; Nogalamycin | 1990 |
Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Liver Neoplasms; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1986 |
A phase I study of menogaril in patients with advanced cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Daunorubicin; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Hematologic Diseases; Humans; Kinetics; Male; Menogaril; Middle Aged; Nausea; Nogalamycin; Stroke Volume | 1987 |
Caring for patients with acute myelocytic leukemia.
Topics: Bone Marrow; Daunorubicin; Hematologic Diseases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Oral Hygiene; Uric Acid | 1988 |
Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Drug Evaluation; Hematologic Diseases; Humans; Idarubicin; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Skin Neoplasms | 1986 |
Idarubicin in advanced breast cancer: a phase II study.
Topics: Aged; Breast Neoplasms; Daunorubicin; Drug Evaluation; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Idarubicin; Middle Aged; Neoplasm Metastasis | 1986 |
[Thrombocyte replacement in hematologic diseases].
Topics: Acute Disease; Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Blood Platelets; Blood Transfusion; Bone Marrow Transplantation; Child; Child, Preschool; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Doxorubicin; Fever; Hematologic Diseases; Hemorrhage; Histocompatibility; HLA Antigens; Humans; Leukemia; Leukemia, Myeloid, Acute; Middle Aged; Plateletpheresis | 1985 |
[Experimental study on antineoplastic agents causing hematopoietic diseases].
Topics: Animals; Antineoplastic Agents; Bleomycin; Dactinomycin; Daunorubicin; Erythrocyte Count; Hematologic Diseases; Hematopoietic System; Leukocyte Count; Methotrexate; Mice; Vincristine | 1972 |
[Immature cell panmyelosis].
Topics: Acid Phosphatase; Adult; Antibiotics, Antineoplastic; Asparaginase; Blood Transfusion; Bone Marrow Examination; Daunorubicin; Drug Combinations; Esterases; Glucuronidase; Hematologic Diseases; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Male; Megakaryocytes; Methotrexate; Peroxidases; Prednisolone; Spleen; Staining and Labeling; Thrombocytopenia; Vincristine | 1973 |
[Clinical usefulness of eticholanolone in the evaluation of bone marrow reserves in patients treated with myelosuppressive drugs and with radiotherapy].
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Bone Marrow Diseases; Bone Marrow Examination; Busulfan; Chlorambucil; Cortisone; Daunorubicin; Etiocholanolone; Female; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia; Leukocyte Count; Male; Mercaptopurine; Radiation Effects; Vinblastine | 1969 |
[Diseases of the thyroid gland].
Topics: Daunorubicin; Goiter; Graves Disease; Hematologic Diseases; Hodgkin Disease; Humans; Hyperthyroidism; Iodine Isotopes; Myxedema; Prednisone; Reserpine; Skin Manifestations; Thyrotropin; Thyroxine | 1967 |